The Vanguard Group 13D/13G Filings for MaxCyte, Inc. (MXCT)

The Vanguard Group 13D and 13G filings for MaxCyte, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-13
5:09 pm
Purchase
2023-12-2913GMaxCyte, Inc.
MXCT
The Vanguard Group5,282,108
5.090%
5,282,108increase
(New Position)
Filing